Noteworthy - June 2021

June 28, 2021 Providence inScope Content Team

Providence Cancer Institute publishes NEJM article, attends global conference
New England Journal of Medicine article on melanoma

A review article by Brendan D. Curti, M.D., titled “Recent Advances in the Treatment of Melanoma,” has been published in the New England Journal of Medicine.

Dr. Curti, medical director of the melanoma program at Providence Cancer Institute and Franz Chair of Clinical Research at the Earle A. Chiles Research Institute, along with Mark B. Faries, M.D., of Cedars-Sinai in Los Angles, highlighted recent advances in the treatment of melanoma.
https://www.nejm.org/doi/full/10.1056/NEJMra2034861?query=featured_home

Providence cancer research featured at global conference

Researchers from the Earle A. Chiles Research Institute, a division of Providence Cancer Institute, shared their work with oncology professionals from around the world at the 2021 annual meeting of the American Society of Clinical Oncology.

Nearly 20 abstracts from Providence’s team of physician scientists and immunologists were selected for presentation or publication during the meeting.
https://blog.providence.org/cancer/providence-cancer-researchers-highlighted-at-asco21-annual-meeting

My name is hard for Americans to pronounce. Don’t tell me to change it.

In a powerful essay for The Washington Post, Providence cardiologist Xiaoyan Huang, M.D., says she used to wish she had a different, less “difficult” name. Now, however, she treasures it. Read more →

Sign up for Providence Bridge Pedal and Stride – Aug. 8

Hop on your bike or lace up your walking shoes and join in the event that for 25 years has been one of Portland’s most beloved community traditions. There are rides for cyclists of all abilities: longer rides for the more experienced bikers, a family-friendly ride over the downtown bridges and a free, 3-mile ride for the youngest cyclists. If you’re not a cyclist, sign up for Providence Bridge Stride, a 5-mile walk. https://www.providence.org/lp/bridge-pedal

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.
More Content by Providence inScope Content Team

Welcome to your journey for creating a healthier you

Noteworthy - June 2021

About the Author

Previous Article

Next Article

Noteworthy - June 2021

About the Author

Previous Article

Next Article

Most Recent Articles

The Gamma Knife Esprit stereotactic radiosurgery system moves beyond a fixed headframe to target the most challenging areas of the brain with exceptional accuracy.

Thousands upon thousands of cancer patients and family members at Providence have benefited from the life-changing work of Dr. Walter Urba. Learn about his remarkable career.

What is required to make clinical trials accessible to people in Hood River and other Columbia Gorge communities? Learn more about why it's important to expand access to studies and cancer care.

This prestigious award recognizes Dr. Fox’s extraordinary contributions to the field of immunotherapy and his lifelong dedication to advancing cancer research.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes.

Years after the start of the pandemic, more than 200 patients continue to be cared for at Providence for ongoing symptoms that remain from contracting COVID-19. Learn how Providence continues helping.

A new investigator-initiated study for patients with metastatic melanoma and HNSCC aims to evaluate a galectin-3 inhibitor as a way to “remove the brakes” from the immune system.

The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.

A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Being able to assess the level of fibrosis and make appropriate referrals is important in the care of patients with Steatotic Liver Disease (formerly known as Fatty Liver).